MicroMed Technology, Inc., a privately held company, develops products to help patients suffering from congestive heart failure.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Houston
State: Texas
Zip:
Country: United States
According to American Heart Association statistics, 20,000-40,000 patients in the United States would benefit from a heart transplant. The MicroMed DeBakey VAD®, jointly developed with Dr. Michael DeBakey, Dr. George Noon and the National Aeronautics and Space Administration (NASA), has the potential to keep many of these people alive until a donor heart becomes available. Weighing less than four ounces, the device is silent and is approximately 1/10 the size of other pulsatile products on the market. The MicroMed DeBakey VAD® is designed to be a lower-cost, less invasive alternative to the commercially available, larger ventricular assist devices (VADs).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2002 | Series D | 6 | $23M |
C.E. Unterberg, Towbin Charterhouse Group International Essex Woodlands Healthcare Partners Mitsui Global Investment Oxford Bioscience Partners SV Health Investors C.E. Unterberg, Towbin Charterhouse Group International Essex Woodlands Healthcare Partners Mitsui Global Investment Oxford Bioscience Partners SV Health Investors |
3/2000 | Series C | $17.6M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|